AAAAAA

   
Results: 1-9 |
Results: 9
Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9
Authors: Ziske, C Marten, A Schottker, B Buttgereit, P Schakowski, F Gorschluter, M von Rucker, A Scheffold, C Chao, N Sauerbruch, T Schmidt-Wolf, IGH
Citation: C. Ziske et al., Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9, MOL THER, 3(1), 2001, pp. 54-60
Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells
Authors: Kornacker, M Verneris, MR Kornacker, B Scheffold, C Negrin, RS
Citation: M. Kornacker et al., Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells, IMMUNOL LET, 76(3), 2001, pp. 169-173
Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity
Authors: Lefterova, P Marten, A Buttgereit, P Weineck, S Scheffold, C Huhn, D Schmidt-Wolf, IGH
Citation: P. Lefterova et al., Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity, J IMMUNOTH, 23(3), 2000, pp. 304-310
Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures
Authors: Trojaneck, B Niemitz, S Micka, B Lefterova, P Blasczyk, R Scheffold, C Huhn, D Schmidt-Wolf, IGH
Citation: B. Trojaneck et al., Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures, CANC BIO R, 15(2), 2000, pp. 169-174
Expansion of CD3(+)CD56(+) cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy
Authors: Lefterova, P Schakowski, F Buttgereit, P Scheffold, C Huhn, D Schmidt-Wolf, IGH
Citation: P. Lefterova et al., Expansion of CD3(+)CD56(+) cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy, HAEMATOLOG, 85(10), 2000, pp. 1108-1109
Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients
Authors: Marten, A Ziske, C Schottker, B Renoth, S Weineck, S Buttgereit, P Schakowski, F Klingmuller, D Scheffold, C von Rucker, A Sauerbruch, T Schmidt-Wolf, IGH
Citation: A. Marten et al., Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients, INT J COL R, 15(4), 2000, pp. 197-205
Increased sensitivity of myeloid leukemia cell lines: Potential of lovastatin as bone-marrow-purging agent
Authors: Scheffold, C Schottker, B Lefterova, P Csipai, M Glasmacher, A Huhn, D Neubauer, A Schmidt-Wolf, IGH
Citation: C. Scheffold et al., Increased sensitivity of myeloid leukemia cell lines: Potential of lovastatin as bone-marrow-purging agent, ACT HAEMAT, 104(2-3), 2000, pp. 72-79
Induction of apoptosis in B lymphoma cells by activation with CD40L
Authors: Lefterova, P Marten, A Buttgereit, P Schakowski, F Micka, B Scheffold, C Schmidt-Wolf, IGH
Citation: P. Lefterova et al., Induction of apoptosis in B lymphoma cells by activation with CD40L, ACT HAEMAT, 103(3), 2000, pp. 168-171
Potential of autologous immunologic effector cells for prediction of progression of disease in patients with chronic myelogenous leukemia
Authors: Muller, M Scheffold, C Lefterova, P Huhn, D Neubauer, A Schmidt-Wolf, IGH
Citation: M. Muller et al., Potential of autologous immunologic effector cells for prediction of progression of disease in patients with chronic myelogenous leukemia, LEUK LYMPH, 31(3-4), 1998, pp. 335-341
Risultati: 1-9 |